Emily Bergsland is an Oncology physician affiliated with University of California, San Francisco. OpenAlex indexes 364 publications with 18,004 citations (h-index 56); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 Divisadero St
San Francisco, CA 941153010
Telephone
415-353-9888Registry record last updated 11 Sept 2025.
Clinical trials
- Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
Sponsor: University of California, San Francisco
- Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
Sponsor: University of California, San Francisco
- Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20251 payment
- TAIHO ONCOLOGY, INC.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- Cancer Research Training and Education Coordination
University of California, San Francisco
FY2026$361,621P30CA082103 - UCSF Paul Calabresi K12 Career Development Program in Clinical Oncology
University of California, San Francisco
FY2025$643,767K12CA260225 - Cancer Research Training and Education Coordination
University of California, San Francisco
FY2025$366,041P30CA082103
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2021 - Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms
Endocrine Related Cancer
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”